Stock BLAU3 BLAU FARMACÊUTICA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Blau Farmacêutica S.A.

Equities

BLAU3

BRBLAUACNOR8

Pharmaceuticals

Delayed Sao Paulo
Other stock markets
 15:03:25 26/06/2024 BST 		5-day change 1st Jan Change
9.68 BRL -6.35% Intraday chart for Blau Farmacêutica S.A. +0.41% -41.01%
05-08 Transcript : Blau Farmacêutica S.A., Q1 2024 Earnings Call, May 08, 2024
05-07 Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Blau Farmaceutica SA is a Brazil-based company engaged in the pharmaceuticals sector. The Company focuses on the development, production and commercialization of medicines, which aim at treatment in the areas of oncology, nephrology, hematology and infectology, among others. Its product lines includes biopharmaceuticals, biosimilars, oncological - injectable, oncological - oral, blood products, antiviral and antiretrovirals, uterine stimulators, anaesthetics, antithrombotics, thrombolytics, female health care, antibiotics, non-beta lactams, cephalosporin, chloramphenicol, acid pumper inhibitor and other hospital products. The Company operates in Brazil, Argentina, Colombia, Peru, Uruguay, Chile and the United States, having a pharmaceutical industrial complex composed of five industrial plants, dedicated to the production of biological, biotechnological and oncological medicines, antibiotics, injectable anesthetics and biotechnological inputs.

Number of employees: 1,900

Sales per Business

BRL in Million2022Weight2023Weight Delta
Institutional
86.0 %
1,277 90.8 % 1,181 86.0 % -7.58%
Non-Institutional
14.0 %
129 9.2 % 192 14.0 % +48.29%

Sales per region

BRL in Million2022Weight2023Weight Delta
Brazil
91.4 %
1,282 91.1 % 1,254 91.4 % -2.15%
Colombia
3.2 %
34 2.4 % 44 3.2 % +27.65%
Uruguay
2.9 %
55 3.9 % 40 2.9 % -28.14%
United States
2.0 %
15 1.1 % 27 2.0 % +74.48%
Chile
0.3 %
9 0.6 % 5 0.3 % -47.06%
Peru
0.2 %
3 0.2 % 3 0.2 % +19.36%

Managers

Managers TitleAgeSince
Marcelo Rodolfo Hahn FOU
 Founder - 17/12/87
Douglas Leandro Rodrigues DFI
 Director of Finance/CFO - 30/04/18
Roberto Altieri CMP
 Compliance Officer - 31/12/13
Roberto Carlos de Campos Morais COO
 Chief Operating Officer 58 -

Members of the board

Members of the board TitleAgeSince
José Antônio Miguel Neto BRD
 Director/Board Member 61 -
Roberto Carlos de Campos Morais COO
 Chief Operating Officer 58 -
Marcelo Rodolfo Hahn FOU
 Founder - 17/12/87
Antonio Carlos Buzaid BRD
 Director/Board Member - -
Rodolfo Alfredo Gerardo Hahn CHM
 Chairman - 31/12/10
Andrea Destri Goncalves dos Santos BRD
 Director/Board Member - -
Simone Petroni Agra BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 179,393,939 29,501,044 ( 16.44 %) 1,713,200 ( 0.9550 %) 16.44 %

Shareholders

NameEquities%Valuation
Marcelo Rodolfo Hahn
82.50 %
147,999,999 82.50 % 289 M R$
Ártica Gestão de Recursos Ltda.
0.5004 %
897,700 0.5004 % 2 M R$
Vokin Administração de Recursos LTDA
0.3314 %
594,600 0.3314 % 1 M R$
BTG Pactual WM Gestão de Recursos Ltda.
0.2865 %
514,000 0.2865 % 1 M R$
Athena Capital Gestão de Recursos Ltda.
0.1331 %
238,700 0.1331 % 465 969 R$
Claritas Administração de Recursos Ltda.
0.1120 %
201,000 0.1120 % 392 374 R$
Hix Investimentos Ltda.
0.1105 %
198,200 0.1105 % 386 908 R$
Ventor Investimentos Ltda.
0.1022 %
183,351 0.1022 % 357 921 R$
Pandhora Investimentos Ltda.
0.0687 %
123,300 0.0687 % 240 695 R$
Leblon Equities Gestão de Recursos Ltda.
0.0662 %
118,830 0.0662 % 231 969 R$

Company contact information

Blau Farmacêutica SA

Rodovia Raposo Tavares, 2833 km 30,5

06705-030, Cotia

+

http://www.blau.com.br
address Blau Farmacêutica S.A.(BLAU3)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Blau Farmacêutica S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
7
Last Close Price
9.71 BRL
Average target price
13.57 BRL
Spread / Average Target
+39.77%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BLAU FARMACÊUTICA S.A. Stock Blau Farmacêutica S.A.
-41.01% 317M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.26% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+45.39% 654B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.83% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+21.51% 337B
ABBVIE INC. Stock AbbVie Inc.
+10.30% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.91% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+2.21% 229B
NOVARTIS AG Stock Novartis AG
+12.84% 219B
AMGEN INC. Stock Amgen Inc.
+9.62% 171B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BLAU3 Stock
  4. Company Blau Farmacêutica S.A.